U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 – May 2023
During December 2020 through May 2023, the Centers for Disease Control and Prevention’s (CDC) Immunization Services Division supported and executed the largest vaccine distribution effort in U.S. history, delivering nearly one billion doses of COVID-19 vaccine to vaccine providers in all 50 states,...
Gespeichert in:
Veröffentlicht in: | Vaccine 2024-09, Vol.42 (Suppl 3), p.125703-125703, Article 125703 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 125703 |
---|---|
container_issue | Suppl 3 |
container_start_page | 125703 |
container_title | Vaccine |
container_volume | 42 |
creator | Duggar, Christopher Santoli, Jeanne M. Noblit, Cameron Moore, Lori B. El Kalach, Roua Bridges, Carolyn B. |
description | During December 2020 through May 2023, the Centers for Disease Control and Prevention’s (CDC) Immunization Services Division supported and executed the largest vaccine distribution effort in U.S. history, delivering nearly one billion doses of COVID-19 vaccine to vaccine providers in all 50 states, District of Columbia, Puerto Rico, Virgin Islands, Guam, Federated States of Micronesia, American Samoa, Marshall Islands, Northern Mariana Islands, and Palau. While existing infrastructure, ordering, and distribution mechanisms were in place from the Vaccines for Children Program (VFC) and experience had been gained during the 2009 H1N1 pandemic and incorporated into influenza vaccination pandemic planning, the scale and complexity of the national mobilization against a novel coronavirus resulted in many previously unforeseen challenges, particularly related to transporting and storing the majority of the U.S. COVID-19 vaccine at frozen and ultra-cold temperatures.
This article describes the infrastructure supporting the distribution of U.S. government-purchased COVID-19 vaccines that was in place pre-pandemic, and the infrastructure, processes, and communications efforts developed to support the heightened demands of the COVID-19 vaccination program, and describes lessons learned. |
doi_str_mv | 10.1016/j.vaccine.2024.02.020 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11366301</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X24001671</els_id><sourcerecordid>2928247931</sourcerecordid><originalsourceid>FETCH-LOGICAL-c444t-926430a72d3efced8bb26a560afd54ad734881db201c4cae95577d40008096e53</originalsourceid><addsrcrecordid>eNqFUcluFDEQtRCIDIFPAFniwmG68drLCaEJS6SgHCCIm-W2q4NH3fbE7h5pbvwDf8iX4FaGsFyQSqqy6tWren4IPaWkpIRWL7flXhvjPJSMMFESloPcQyva1Lxgkjb30YqwShSCki8n6FFKW0KI5LR9iE54wysi6mqFpqvyY4k3l5_Pzwra4iMnti5N0XXz5ILHudQTXDtIa5wOaYIxFzuIfYij9gbWWHuLB0gp-JSzjh7sGp-BgbGDiPOBBP_49h1_0IflwR-jB70eEjw55lN09fbNp8374uLy3fnm9UVhhBBT0ebzOdE1sxx6A7bpOlZpWRHdWym0rbloGmo7RqgRRkMrZV1bkWU2pK1A8lP06pZ3N3cjWAM-KxnULrpRx4MK2qm_O959VddhryjlVcUJzQwvjgwx3MyQJjW6ZGAYtIcwJ8Va1jBRt3yBPv8Hug1z9Fmfyl0m5QLNKHmLMjGkFKG_u4YStRirtupoglqMVYTlIHnu2Z9S7qZ-OflbK-QP3TuIKhkH2R3rIphJ2eD-s-Inu8-1mw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3132559282</pqid></control><display><type>article</type><title>U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 – May 2023</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Duggar, Christopher ; Santoli, Jeanne M. ; Noblit, Cameron ; Moore, Lori B. ; El Kalach, Roua ; Bridges, Carolyn B.</creator><creatorcontrib>Duggar, Christopher ; Santoli, Jeanne M. ; Noblit, Cameron ; Moore, Lori B. ; El Kalach, Roua ; Bridges, Carolyn B.</creatorcontrib><description>During December 2020 through May 2023, the Centers for Disease Control and Prevention’s (CDC) Immunization Services Division supported and executed the largest vaccine distribution effort in U.S. history, delivering nearly one billion doses of COVID-19 vaccine to vaccine providers in all 50 states, District of Columbia, Puerto Rico, Virgin Islands, Guam, Federated States of Micronesia, American Samoa, Marshall Islands, Northern Mariana Islands, and Palau. While existing infrastructure, ordering, and distribution mechanisms were in place from the Vaccines for Children Program (VFC) and experience had been gained during the 2009 H1N1 pandemic and incorporated into influenza vaccination pandemic planning, the scale and complexity of the national mobilization against a novel coronavirus resulted in many previously unforeseen challenges, particularly related to transporting and storing the majority of the U.S. COVID-19 vaccine at frozen and ultra-cold temperatures.
This article describes the infrastructure supporting the distribution of U.S. government-purchased COVID-19 vaccines that was in place pre-pandemic, and the infrastructure, processes, and communications efforts developed to support the heightened demands of the COVID-19 vaccination program, and describes lessons learned.</description><identifier>ISSN: 0264-410X</identifier><identifier>ISSN: 1873-2518</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2024.02.020</identifier><identifier>PMID: 38360476</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>At risk populations ; Centers for Disease Control and Prevention, U.S ; Coronaviruses ; COVID-19 ; COVID-19 - epidemiology ; COVID-19 - prevention & control ; COVID-19 pandemic ; COVID-19 vaccine ; COVID-19 vaccines ; COVID-19 Vaccines - administration & dosage ; Disease control ; Drug stores ; Emergency preparedness ; Humans ; Illnesses ; Immunization ; Immunization Programs - organization & administration ; Information systems ; Infrastructure ; Inventory ; Islands ; Lessons learned ; Medicaid ; Older people ; Pandemics ; Pandemics - prevention & control ; Pediatrics ; Pharmacy ; Public health ; SARS-CoV-2 - immunology ; Severe acute respiratory syndrome coronavirus 2 ; Swine flu ; United States - epidemiology ; Vaccination ; Vaccine distribution ; Vaccines</subject><ispartof>Vaccine, 2024-09, Vol.42 (Suppl 3), p.125703-125703, Article 125703</ispartof><rights>2024 The Author(s)</rights><rights>Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.</rights><rights>2024. The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c444t-926430a72d3efced8bb26a560afd54ad734881db201c4cae95577d40008096e53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/3132559282?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,780,784,885,3548,27922,27923,45993,64383,64385,64387,72239</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38360476$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Duggar, Christopher</creatorcontrib><creatorcontrib>Santoli, Jeanne M.</creatorcontrib><creatorcontrib>Noblit, Cameron</creatorcontrib><creatorcontrib>Moore, Lori B.</creatorcontrib><creatorcontrib>El Kalach, Roua</creatorcontrib><creatorcontrib>Bridges, Carolyn B.</creatorcontrib><title>U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 – May 2023</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>During December 2020 through May 2023, the Centers for Disease Control and Prevention’s (CDC) Immunization Services Division supported and executed the largest vaccine distribution effort in U.S. history, delivering nearly one billion doses of COVID-19 vaccine to vaccine providers in all 50 states, District of Columbia, Puerto Rico, Virgin Islands, Guam, Federated States of Micronesia, American Samoa, Marshall Islands, Northern Mariana Islands, and Palau. While existing infrastructure, ordering, and distribution mechanisms were in place from the Vaccines for Children Program (VFC) and experience had been gained during the 2009 H1N1 pandemic and incorporated into influenza vaccination pandemic planning, the scale and complexity of the national mobilization against a novel coronavirus resulted in many previously unforeseen challenges, particularly related to transporting and storing the majority of the U.S. COVID-19 vaccine at frozen and ultra-cold temperatures.
This article describes the infrastructure supporting the distribution of U.S. government-purchased COVID-19 vaccines that was in place pre-pandemic, and the infrastructure, processes, and communications efforts developed to support the heightened demands of the COVID-19 vaccination program, and describes lessons learned.</description><subject>At risk populations</subject><subject>Centers for Disease Control and Prevention, U.S</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 - prevention & control</subject><subject>COVID-19 pandemic</subject><subject>COVID-19 vaccine</subject><subject>COVID-19 vaccines</subject><subject>COVID-19 Vaccines - administration & dosage</subject><subject>Disease control</subject><subject>Drug stores</subject><subject>Emergency preparedness</subject><subject>Humans</subject><subject>Illnesses</subject><subject>Immunization</subject><subject>Immunization Programs - organization & administration</subject><subject>Information systems</subject><subject>Infrastructure</subject><subject>Inventory</subject><subject>Islands</subject><subject>Lessons learned</subject><subject>Medicaid</subject><subject>Older people</subject><subject>Pandemics</subject><subject>Pandemics - prevention & control</subject><subject>Pediatrics</subject><subject>Pharmacy</subject><subject>Public health</subject><subject>SARS-CoV-2 - immunology</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Swine flu</subject><subject>United States - epidemiology</subject><subject>Vaccination</subject><subject>Vaccine distribution</subject><subject>Vaccines</subject><issn>0264-410X</issn><issn>1873-2518</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFUcluFDEQtRCIDIFPAFniwmG68drLCaEJS6SgHCCIm-W2q4NH3fbE7h5pbvwDf8iX4FaGsFyQSqqy6tWren4IPaWkpIRWL7flXhvjPJSMMFESloPcQyva1Lxgkjb30YqwShSCki8n6FFKW0KI5LR9iE54wysi6mqFpqvyY4k3l5_Pzwra4iMnti5N0XXz5ILHudQTXDtIa5wOaYIxFzuIfYij9gbWWHuLB0gp-JSzjh7sGp-BgbGDiPOBBP_49h1_0IflwR-jB70eEjw55lN09fbNp8374uLy3fnm9UVhhBBT0ebzOdE1sxx6A7bpOlZpWRHdWym0rbloGmo7RqgRRkMrZV1bkWU2pK1A8lP06pZ3N3cjWAM-KxnULrpRx4MK2qm_O959VddhryjlVcUJzQwvjgwx3MyQJjW6ZGAYtIcwJ8Va1jBRt3yBPv8Hug1z9Fmfyl0m5QLNKHmLMjGkFKG_u4YStRirtupoglqMVYTlIHnu2Z9S7qZ-OflbK-QP3TuIKhkH2R3rIphJ2eD-s-Inu8-1mw</recordid><startdate>20240917</startdate><enddate>20240917</enddate><creator>Duggar, Christopher</creator><creator>Santoli, Jeanne M.</creator><creator>Noblit, Cameron</creator><creator>Moore, Lori B.</creator><creator>El Kalach, Roua</creator><creator>Bridges, Carolyn B.</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20240917</creationdate><title>U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 – May 2023</title><author>Duggar, Christopher ; Santoli, Jeanne M. ; Noblit, Cameron ; Moore, Lori B. ; El Kalach, Roua ; Bridges, Carolyn B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c444t-926430a72d3efced8bb26a560afd54ad734881db201c4cae95577d40008096e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>At risk populations</topic><topic>Centers for Disease Control and Prevention, U.S</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 - prevention & control</topic><topic>COVID-19 pandemic</topic><topic>COVID-19 vaccine</topic><topic>COVID-19 vaccines</topic><topic>COVID-19 Vaccines - administration & dosage</topic><topic>Disease control</topic><topic>Drug stores</topic><topic>Emergency preparedness</topic><topic>Humans</topic><topic>Illnesses</topic><topic>Immunization</topic><topic>Immunization Programs - organization & administration</topic><topic>Information systems</topic><topic>Infrastructure</topic><topic>Inventory</topic><topic>Islands</topic><topic>Lessons learned</topic><topic>Medicaid</topic><topic>Older people</topic><topic>Pandemics</topic><topic>Pandemics - prevention & control</topic><topic>Pediatrics</topic><topic>Pharmacy</topic><topic>Public health</topic><topic>SARS-CoV-2 - immunology</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Swine flu</topic><topic>United States - epidemiology</topic><topic>Vaccination</topic><topic>Vaccine distribution</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Duggar, Christopher</creatorcontrib><creatorcontrib>Santoli, Jeanne M.</creatorcontrib><creatorcontrib>Noblit, Cameron</creatorcontrib><creatorcontrib>Moore, Lori B.</creatorcontrib><creatorcontrib>El Kalach, Roua</creatorcontrib><creatorcontrib>Bridges, Carolyn B.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Duggar, Christopher</au><au>Santoli, Jeanne M.</au><au>Noblit, Cameron</au><au>Moore, Lori B.</au><au>El Kalach, Roua</au><au>Bridges, Carolyn B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 – May 2023</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2024-09-17</date><risdate>2024</risdate><volume>42</volume><issue>Suppl 3</issue><spage>125703</spage><epage>125703</epage><pages>125703-125703</pages><artnum>125703</artnum><issn>0264-410X</issn><issn>1873-2518</issn><eissn>1873-2518</eissn><abstract>During December 2020 through May 2023, the Centers for Disease Control and Prevention’s (CDC) Immunization Services Division supported and executed the largest vaccine distribution effort in U.S. history, delivering nearly one billion doses of COVID-19 vaccine to vaccine providers in all 50 states, District of Columbia, Puerto Rico, Virgin Islands, Guam, Federated States of Micronesia, American Samoa, Marshall Islands, Northern Mariana Islands, and Palau. While existing infrastructure, ordering, and distribution mechanisms were in place from the Vaccines for Children Program (VFC) and experience had been gained during the 2009 H1N1 pandemic and incorporated into influenza vaccination pandemic planning, the scale and complexity of the national mobilization against a novel coronavirus resulted in many previously unforeseen challenges, particularly related to transporting and storing the majority of the U.S. COVID-19 vaccine at frozen and ultra-cold temperatures.
This article describes the infrastructure supporting the distribution of U.S. government-purchased COVID-19 vaccines that was in place pre-pandemic, and the infrastructure, processes, and communications efforts developed to support the heightened demands of the COVID-19 vaccination program, and describes lessons learned.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>38360476</pmid><doi>10.1016/j.vaccine.2024.02.020</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0264-410X |
ispartof | Vaccine, 2024-09, Vol.42 (Suppl 3), p.125703-125703, Article 125703 |
issn | 0264-410X 1873-2518 1873-2518 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11366301 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland |
subjects | At risk populations Centers for Disease Control and Prevention, U.S Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 pandemic COVID-19 vaccine COVID-19 vaccines COVID-19 Vaccines - administration & dosage Disease control Drug stores Emergency preparedness Humans Illnesses Immunization Immunization Programs - organization & administration Information systems Infrastructure Inventory Islands Lessons learned Medicaid Older people Pandemics Pandemics - prevention & control Pediatrics Pharmacy Public health SARS-CoV-2 - immunology Severe acute respiratory syndrome coronavirus 2 Swine flu United States - epidemiology Vaccination Vaccine distribution Vaccines |
title | U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 – May 2023 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T15%3A18%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=U.S.%20COVID-19%20vaccine%20distribution%20strategies,%20systems,%20performance,%20and%20lessons%20learned,%20December%202020%20%E2%80%93%20May%202023&rft.jtitle=Vaccine&rft.au=Duggar,%20Christopher&rft.date=2024-09-17&rft.volume=42&rft.issue=Suppl%203&rft.spage=125703&rft.epage=125703&rft.pages=125703-125703&rft.artnum=125703&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2024.02.020&rft_dat=%3Cproquest_pubme%3E2928247931%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3132559282&rft_id=info:pmid/38360476&rft_els_id=S0264410X24001671&rfr_iscdi=true |